IFNA1 and autoimmune polyendocrinopathy: In 2008, the results of a genome-wide array study showed that a total of 93 genes were differentially expressed between primary APS patients and healthy controls, with both type I and type II IFN-induced families showing upregulated expression in PAPS subjects (30).